Free shipping on all orders over $ 500

WEHI-345

Cat. No. M8951
WEHI-345 Structure
Size Price Availability Quantity
5mg USD 130  USD130 In stock
10mg USD 205  USD205 In stock
50mg USD 720  USD720 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

WEHI-345 is a potent and selective RIPK2 inhibitor which shows NOD signalling events yet prevents inflammatory cytokine production. WEHI-345 delays RIPK2 ubiquitylation and NF-κB activation downstream of NOD engagement. WEHI-345 proved to be highly specific for RIPK2(Kd=46 nM) and displayed negligible activity (>10 μM) against RIPK1, RIPK4 and RIPK5.

In vivo, WEHI-345 ameliorates experimental autoimmune encephalomyelitis in mice. WEHI-345 also potently inhibited MDP-induced cytokine and chemokine secretion in the mouse macrophage Raw 264.7 cell line.

Product Citations
Chemical Information
Molecular Weight 401.46
Formula C22H23N7O
CAS Number 1354825-58-3
Solubility (25°C) DMSO: ≥ 25 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Nachbur U, et al. Nat Commun. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.

Related RIPK Products
RIPK1-IN-12

RIPK1-IN-12 is a potent RIPK1 inhibitor.

DNL747

DNL747 is an ASK1 and RIPK1 inhibitor for studies related to Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis.

DNL104

DNL104 is a RIPK1 inhibitor that can be used in Alzheimer's disease related studies.

mRNA-0184

mRNA-0184 is a relaxin mimetic and also a relaxin receptor-1 (RXFP1) agonist.

AZD-3427

AZD-3427 is an RXFP1 agonist that may be used in studies related to cardiovascular disease.

  Catalog
Abmole Inhibitor Catalog




Keywords: WEHI-345 supplier, RIPK, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.